-
What are signs of hypoglycemia?
- Tachycardia
- Confusion
- Sweating
- Drowsiness
-
List (3) rapid acting insulins.
- insulin aspart (NovoLog)
- insulin glulisine (Apidra)
- insulin lispro (Humalog)
-
List (2) short acting insulins.
- insulin regular (Humulin R)
- insulin regular (Novolin R)
-
List (2) intermediate acting insulins
- isophane susp (NPH, Humulin N)
- isophane susp (NPH, Novolin N)
-
Which insulin(s) have no peak time?
- insulin detemir (Levemir)
- insulin glargine (Lantus)
-
Which insulin(s) must be given seperately?
- insulin detemir (Levemir)
- insulin glargine (Lantus)
-
Which insulin(s) can be given IV?
- isophane susp (NPH, Humulin N)
- isophane susp (NPH, Novolin N)
-
Which insulin(s) are cloudy?
- isophane susp (NPH, Humulin N)
- isophane susp (NPH, Novolin N)
-
insulin aspart (NovoLog)
- Type: Rapid Acting
- Onset: 10-20 min
- Peak: 1-3 hr
- Duration: 3-5 hr
-
In what order are insulins mixed?
- Draw total amount of air into syringe
- Place air into NPH (cloudy)
- Place air into Regular
- Draw Regular
- Draw NPH (cloudy)
- (Nancy Reagan, Registered Nurse)
-
insulin lispro (Humalog)
- Type: Rapid Acting
- Onset: 5-15 min
- Peak: 1–1.5 hr
- Duration: 3-4 hr
-
insulin glulisine (Apidra)
- Type: Rapid Acting
- Onset: 15-30 min
- Peak: 1 hr
- Duration: 3-4 hr
-
insulin regular (Humulin R, Novolin R)
- Type: Short Acting
- Onset: 30-60 min
- Peak: 1-5 hr
- Duration: 6-10 hr
-
isophane susp (NPH, Humulin N, Novolin N)
- Type: Intermediate Acting
- Onset: 1-2 hr
- Peak: 6-14 hr
- Duration: 16-24 hr
-
Humulin 70/30
- Type: Combination
- Preparation:
- .... 70% isophane susp
- .... 30% insulin regular
- Onset: 0.5
- Peak: 6-10
- Duration: 10-16
-
Novolin 70/30
- Type: Combination
- Preparation:
- .... 70% isophane susp
- .... 30% insulin regular
- Onset: 0.5
- Peak: 6-10
- Duration: 10-16
-
Humulin 50/50
- Type: combination
- Preparation:
- .... 50% isophane susp
- .... 50% insulin regular
- Onset: 0.5
- Peak: 3-5
- Duration:
-
Novolog Mix 70/30
- Type: combination
- Preparation:
- .... 70% insulin aspart protamine susp
- .... 30% insulin aspart susp
- Onset: 0.25 (15 min)
- Peak: 1-4
- Duration: 18-24
-
Humalog Mix 75/25
- Type: combination
- Preparation:
- .... 75% insulin lispro protamine suspension
- .... 25% insulin lispro
- Onset: 0.25 (15 min)
- Peak: 1-2
- Duration: 18-24
-
insulin detemir (Levemir)
- Type: Long Acting
- Onset: 1
- Peak: None
- Duration: 5.7-24
-
insulin glargine (Lantus)
- Type: Long Acting
- Onset: 2
- Peak: None
- Duration: 24
-
List (7) oral hypoglycemics.
- Alpha-glucosidase inhibitors
- Biguanide
- Meglitinides
- Sulfonylureas, first generation
- Sulfonylureas, second generation
- Thiazolidinediones
- Miscellaneous drugs
-
List (2) alpha-glucosidase inhibitors.
- acarbose (Precose)
- miglitol (Glyset)
-
List variations of biguanide.
- metformin
- .... immediate release (Glucophage, Riomet)
- .... extended release (Fortamet, Glucophage XR, Glumetza)
-
List (3) first generation sulfonylureas.
- chlorpromamide (Diabinese)
- tolazamide (Tolinase)
- tolbutamide (Orinase)
-
List (4) second generation sulfonylureas.
- glimepiride (Amaryl)
- glipizide (Glucotrol)
- glyburide (DiaBeta)
- glyburide micronized tablets (Micronase)
-
List (2) thiazolidinediones
- pioglitazone (Actos)
- roziglitazone (Avandia)
-
List (4) miscellaneous oral hypoglycemics.
- bromocriptine (Cycloset)
- exenatide (Byetta)
- pramlintide (Symlyn)
- sitagliptin (Januvia)
-
glimepriride, (Amaryl, Apo-Glimepiride, Novo-Glimepiride)
- Common Oral Antidiabetic Drug
- Second-Generation Sulfonylurea
-
glipizide, (Glucotrol)
- Common Oral Antidiabetic Drug
- Second-Generation Sulfonylurea
-
glyBURIDE, (Apo-Glyburide, Diabeta, Gen-Glybe, Euglucon, Micronase)
- Common Oral Antidiabetic Drug
- Second-Generation Sulfonylurea
-
glyBURIDE, micronized (Glynase Pres-Tab)
- Common Oral Antidiabetic Drug
- Second-Generation Sulfonylurea
-
nateglinide, (Starlix)
- Common Oral Antidiabetic Drug
- Meglitinide
-
repaglinide, (Gluco Norm, Prandin)
- Common Oral Antidiabetic Drug
- Meglitinide
-
metformin, (APO-Metformin, Fortamet, Glucophage, Glumetza, Glycon, Riomet)
- Common Oral Antidiabetic Drug
- Biguanide
-
acarbose, (Prandase, Precose)
- Common Oral Antidiabetic Drug
- Alpha – Glucosidase Inhibitor
-
miglitol (Glyset)
- Common Oral Antidiabetic Drug
- Alpha – Glucosidase Inhibitor
-
Pioglitazone, (Actos, Apo-Pioglitazone, Novo-ioglitazone)
- Common Oral Antidiabetic Drugs
- Thiazolidinedione
-
Rosiglitazone (Avandia)
- Common Oral Antidiabetic Drug
- Thiazolidinedione
-
Exenatide (Byetta)
- Incretin Analog
- Common drug that increases incretins and amylin
-
Liraglutide (Victoza)
- Incretin Analog
- Common drug that increases incretins and amylin
-
Pramlintide, (Symlin)
- Amylin Analog
- Common drug that increases incretins and amylin
-
Sitagliptin (Januvia)
- DDP-IV Inhibitor
- Common drug that increases incretins and amylin
-
human regular insulin (Humulin R, Novolin R)
- Therapeutic Class: Antidiabetic agent; pancreatic hormone
- Phamacologic Class: Short acting hypoglycemic agent
- Action:
- .. Promote:
- ...... cellular uptake of glucose, amino acids, and potassium
- ...... protein synthesis, glycogen formation and storage
- ...... fatty acid storage as triglycerides
- ...... utilization of glucose for energy needs
- .. Inhibit gluconeogenesis
- Adverse Effects: Hypoglycemia, weight gain
|
|
